Pay in 4 interest-free payments of $5.75 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
The Science Behind Retatrutide's Triple Mechanism Each of retatrutide's three receptor targets contributes unique metabolic benefits: GIP Receptor Activation: Enhances insulin secretion in response to food intake Influences fat metabolism and storage patterns Modulates bone metabolism and cardiovascular function Complements GLP-1 effects for improved glycemic control GLP-1 Receptor Activation: Stimulates insulin release while suppressing glucagon Slows gastric emptying to extend satiety Reduces appetite through central nervous system pathways Provides cardiovascular protective effects Glucagon Receptor Activation: Increases energy expenditure and metabolic rate Promotes fat oxidation and lipolysis Helps prevent metabolic adaptation during weight loss Balances the anabolic effects of insulin signaling This triple-action approach explains why retatrutide demonstrated remarkable results in phase 2 clinical trials, with participants experiencing up to 24.2% body weight reduction at 48 weeks [4]
Certain overgrown pathogenic bacteria produce high levels of their own rogue protease enzymes
It activates melanocortin receptors MC1R and MC3R, suppressing NF-kappaB nuclear translocation and consequently reducing pro-inflammatory cytokine production including TNF-alpha, IL-6, and IL-1beta
96 (17), e6723
